IP Library Granted Patent US 9,586,937
Granted Patent B2
US 9,586,937 · App. 15/215,628 · Granted Mar 7, 2017

sGC stimulators

Inventors: Takashi Nakai (Newton, MA); Joel Moore (Lexington, MA); Nicholas Robert Perl (Somerville, MA); Rajesh R. Iyengar (West Newton, MA); Ara Mermerian (Waltham, MA); G-Yoon Jamie Im (Cambridge, MA); Thomas Wai-Ho Lee (Lexington, MA); Colleen Hudson (Malden, MA); Glen Robert Rennie (Somerville, MA); James Jia (Belmont, MA); Paul Allan Renhowe (Sudbury, MA); Timothy Claude Barden (Salem, MA); Xiang Y. Yu (Acton, MA); James Edward Sheppeck (Newtown, PA); Karthik Iyer (Cambridge, MA); Joon Jung (Newton, MA); George Todd Milne (Brookline, MA); Kimberly Kafadar Long (Boston, MA); Mark G. Currie (Boston, MA)
Assignee: IRONWOOD PHARMACEUTICALS, INC.
C07D403/04A61K31/506A61K31/517A61K31/519A61K31/5377A61K31/541A61K31/55C07D401/14C07D413/14C07D417/14C07D471/08C07D471/10C07D487/04C07D487/10C07D491/107C07D498/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,586,937
App. No.
15/215,628
Granted
Mar 7, 2017
Kind
B2
Abstract

Compounds of Formulae I′ and I are described, which are useful as stimulators of sGC, particularly NO-independent, heme-dependent stimulators. These compounds are also useful for treating, preventing or managing various disorders that are herein disclosed.

Claims (3)

1. A compound of formula:

or a pharmaceutically acceptable salt thereof.

2. A pharmaceutical composition comprising a compound of claim 1 , or a pharmaceutically acceptable salt thereof, and one or more excipients.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 10, 2019
From: IRONWOOD PHARMACEUTICALS, INC.
To: CYCLERION THERAPEUTICS, INC.
Reel/Frame 048853/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 4, 2016
From: NAKAI, TAKASHI; MOORE, JOEL; PERL, NICHOLAS ROBERT; IYENGAR, RAJESH R.; MERMERIAN, ARA; IM, G-YOON JAMIE; LEE, THOMAS WAI-HO; HUDSON, COLLEEN; RENNIE, GLEN ROBERT; JIA, JAMES; RENHOWE, PAUL ALLAN; JUNG, JOON; BARDEN, TIMOTHY CLAUDE; YU, XIANG Y.; SHEPPECK, JAMES EDWARD, II; IYER, KARTHIK; MILNE, GEORGE TODD; LONG, KIMBERLY KAFADAR; CURRIE, MARK G.
To: IRONWOOD PHARMACEUTICALS, INC.
Reel/Frame 040224/0680 →
Continuity (4)
Continuation 14775954
Provisional Application 61790637 · Mar 15, 2013
Provisional Application 61914915 · Dec 11, 2013
Related Publication 20160347738A1 · Dec 1, 2016